ArticleHaematologica2025

Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy.

Santiago Mercadal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.